Sonnet BioTherapeutics Holdings, Inc. (SONN)
NASDAQ: SONN · Real-Time Price · USD
1.540
0.00 (0.00%)
At close: Jan 21, 2025, 4:00 PM
1.520
-0.020 (-1.30%)
After-hours: Jan 21, 2025, 7:12 PM EST
SONN Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '24 Sep 30, 2024 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 |
| Revenue | 0.02 | 0.02 | 0.15 | 0.35 | 0.48 | - | |
| Revenue Growth (YoY) | -87.40% | -87.40% | -57.76% | -27.64% | - | - | |
| Cost of Revenue | 0.11 | 0.11 | 0.12 | 21.44 | 16.63 | 9.88 | |
| Gross Profit | -0.09 | -0.09 | 0.03 | -21.09 | -16.15 | -9.88 | |
| Selling, General & Admin | 6.13 | 6.13 | 7.13 | 8.58 | 8.94 | 7.53 | |
| Research & Development | 5.63 | 5.63 | 11.69 | - | - | - | |
| Operating Expenses | 11.76 | 11.76 | 18.82 | 8.58 | 8.94 | 7.53 | |
| Operating Income | -11.85 | -11.85 | -18.79 | -29.67 | -25.09 | -17.41 | |
| Interest & Investment Income | - | - | - | - | 0 | 0.02 | |
| Currency Exchange Gain (Loss) | 0.08 | 0.08 | -0.04 | -0.05 | -0.02 | -0.05 | |
| Other Non Operating Income (Expenses) | 4.33 | 4.33 | - | - | - | - | |
| EBT Excluding Unusual Items | -7.44 | -7.44 | -18.83 | -29.72 | -25.11 | -17.44 | |
| Other Unusual Items | - | - | - | - | 0.13 | - | |
| Pretax Income | -7.44 | -7.44 | -18.83 | -29.72 | -24.98 | -24.27 | |
| Net Income | -7.44 | -7.44 | -18.83 | -29.72 | -24.98 | -24.27 | |
| Preferred Dividends & Other Adjustments | - | - | - | - | - | 41.34 | |
| Net Income to Common | -7.44 | -7.44 | -18.83 | -29.72 | -24.98 | -65.6 | |
| Shares Outstanding (Basic) | 1 | 1 | 0 | 0 | - | - | |
| Shares Outstanding (Diluted) | 1 | 1 | 0 | 0 | - | - | |
| Shares Change (YoY) | 404.96% | 404.96% | 425.71% | - | - | - | |
| EPS (Basic) | -11.35 | -11.35 | -145.13 | -1204.14 | - | - | |
| EPS (Diluted) | -11.35 | -11.35 | -145.13 | -1204.14 | - | - | |
| Free Cash Flow | -8.61 | -8.61 | -21.34 | -27.77 | -22.56 | -15.69 | |
| Free Cash Flow Per Share | -13.14 | -13.14 | -164.47 | -1125.21 | - | - | |
| Gross Margin | - | - | 17.96% | - | - | - | |
| Operating Margin | -63617.91% | -63617.91% | -12714.47% | -8478.34% | -5187.36% | - | |
| Profit Margin | -39929.30% | -39929.30% | -12741.58% | -8493.34% | -5165.97% | - | |
| Free Cash Flow Margin | -46213.48% | -46213.48% | -14439.19% | -7936.59% | -4663.91% | - | |
| EBITDA | -11.84 | -11.84 | -18.78 | -29.66 | -25.07 | -17.4 | |
| D&A For EBITDA | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| EBIT | -11.85 | -11.85 | -18.79 | -29.67 | -25.09 | -17.41 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.